Last checked at 12 Aug 2020 13:35
IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair
IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Reneuron Share News (RENE)
RENE Share
Price
RENE Share
News
RENE Share
Chat
RENE Share
Trades
RENE
Live RNS
RENE Share
Charts
RENE Level 2
Console
RENE Live
Share Price
RENE Broker
Ratings
RENE Directors
Deals
RENE Financial
Diary
RENE
Fundamentals
RENE Short
Positions
RENE
Media
Reneuron Information
- This share is currently suspended. It was suspended at a price of 3.275
Share Price Information for Reneuron (RENE)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
3.275
Bid:
0.00
Ask:
0.00
Change:
0.00 (0.00%)
Spread:
0.00 (0.00%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
3.275
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.31 Jul 2020 16:22
ReNeuron gets patent allowance in the US
(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.
Read more31 Jul 2020 11:28
UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce
UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce
Read more29 Jun 2020 20:39
IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment
IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment
Read more25 Jun 2020 14:55
IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm
IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm
Read more25 Jun 2020 11:22
ReNeuron Group inks research evaluation deal with US firm
(Sharecast News) - Cell-based therapeutics company ReNeuron Group announced on Thursday that it has signed a new research evaluation agreement with a major United States biotechnology company, in connection with the use of its proprietary exosomes for the delivery of novel gene silencing therapeutics.
Read more17 Jun 2020 15:58
IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial
IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial
Read more3 Apr 2020 11:41
UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On
UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On
Read more24 Feb 2020 12:24
Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study
Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study
Read more17 Feb 2020 10:29
Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal
Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal
Read more18 Dec 2019 19:08
Woodford Transfers Series Of Holdings To New Manager Schroders
Woodford Transfers Series Of Holdings To New Manager Schroders
Read more6 Dec 2019 10:42
ReNeuron cuts losses after Fosun licence payment
(Sharecast News) - ReNeuron Group on Friday reported a narrower interim loss after receiving payment from a Chinese licensee, while it also made progress in its clinical and research programmes.
Read more6 Dec 2019 09:32
ReNeuron Reports "Strong Progress" Across Various Programmes
ReNeuron Reports "Strong Progress" Across Various Programmes
Read more29 Nov 2019 16:07
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Read more23 Oct 2019 15:50
ReNeuron presents new data on CTX stem cell platform
(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Wednesday that new data relating to its CTX stem cell platform was being presented at the 27th Annual Congress of the European Society of Gene and Cell Therapy in Barcelona.
Read more